Company intelligence
CY Partners
Recruitment consultancy specialising in the science sector.
About CY Partners
Established in 2008, we're global recruiters specialising in sourcing skilled science professionals from entry to executive level in Pharmaceuticals, Biotechnology, Clinical and Chemical sectors. Our team is equipped with experts in recruitment, qualified within the scientific industries we support. Working in partnership with you, we provide a personalised approach to your recruitment needs and offer the following services: Contingency recruitment Professional search Project based recruitment Part outsourced recruitment We connect jobseekers with global opportunities and source top talent for clients worldwide, easing the burdens of job hunting and hiring. We provide a supportive, knowledgeable and professional service, ensuring the right career move or hire for you. Contact us via LinkedIn, email, or phone for personalised service. Trusted long term partners in this dynamic job market, we're here to assist you in joining global Pharma corporations, ambitious Biotech start-ups, or sourcing skilled scientific professionals globally. https://www.cypartners.co.uk info@cypartners.co.uk 0191 477 4733
Verified activity
Signals from CY Partners
5 published signals
Strategy & Corporate Development
CY Partners reports that updated plans under the Life Sciences Sector Plan aim to create 66,000 additional roles by 2035 as the UK targets becoming the third largest life sciences economy globally.
Reported by CY Partners
Capital & Finance
CY Partners reports that the UK life sciences sector has secured over £3 billion in new public and private investment over the past 12 months.
Reported by CY Partners
Capital & Finance
CY Partners reports that average clinical trial setup times for the UK life sciences sector dropped from 169 days to 122 days in the first half of 2025/2026.
Reported by CY Partners
Capital & Finance
CY Partners reports that a joint approval process between the MHRA and NICE is projected to give patients access to new treatments up to six months faster.
Reported by CY Partners
Capital & Finance
CY Partners reports that AstraZeneca has invested £300 million in AI drug discovery across Cambridge and Macclesfield, and Moderna has committed £1 billion in research and development in Oxfordshire.
Reported by CY Partners